QVT Associates GP LLC

10% owner at Jpak Group, Inc. · on record since Aug 20, 2007
10% owner at Pharmasset Inc · on record since Feb 11, 2009
10% owner at INHIBITEX, INC. · on record since Oct 30, 2009
reference remarks (2) below at Molecular Insight Pharmaceuticals, Inc. · on record since Jun 30, 2010
10% owner at ANADYS PHARMACEUTICALS INC · on record since Jun 7, 2010
10% owner at MEDIVATION, INC. · on record since Sep 20, 2010
10% owner at ACHILLION PHARMACEUTICALS INC · on record since Mar 4, 2013
Director at Myovant Sciences Ltd. · on record since Oct 26, 2016
10% owner at CONCERT PHARMACEUTICALS, INC. · on record since Feb 21, 2014
10% owner at AGENUS INC · on record since Feb 14, 2014
Director at Arbutus Biopharma Corp · on record since Mar 16, 2015
10% owner at Sio Gene Therapies Inc. · on record since Jun 10, 2015
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at Myovant Sciences Ltd. · on record since Jun 6, 2019

Insider trading activity of QVT Associates GP LLC

Transactions on record: 132; since Sep 24, 2009

Open-market buys: 84; $53.9M

Open-market sells: 42; $52.3M

Companies traded: 10; last filing Jun 14, 2019

Figures computed from official regulatory filings — .

Companies where QVT Associates GP LLC has traded

Urovant Sciences Ltd.17 tx · $819.4K · Jun 14, 2019
Sio Gene Therapies Inc.2 tx · $20M · Mar 19, 2019
2 tx · $116.4M · Jan 16, 2018
31 tx · $30.1M · Jun 12, 2014
5 tx · $4.2M · Feb 21, 2014
28 tx · $19.6M · Jun 9, 2011
24 tx · $3.6M · Jun 2, 2011
16 tx · $3.9M · Jan 5, 2011
3 tx · $4.7M · Dec 29, 2010
4 tx · $19.2M · Sep 24, 2009

Track record of QVT Associates GP LLC

Statistical track record

Free

Open-market buys: 86

Last buy: Jun 14, 2019

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of QVT Associates GP LLC

Co-insiders of QVT Associates GP LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,367	7.95 USD	$58.6K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,500	8.30 USD	$62.3K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,144	7.91 USD	$56.5K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 11, 2019	Buy	7,189	8.58 USD	$61.7K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 11, 2019	Buy	6,649	7.97 USD	$53K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 11, 2019	Buy	7,500	8.35 USD	$62.6K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	5,071	7.70 USD	$39K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	300	8.91 USD	$2.7K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	5,424	7.71 USD	$41.8K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	6,951	7.97 USD	$55.4K	SEC
Urovant Sciences Ltd.Listing unverified	May 23, 2019	Buy	4,802	7.76 USD	$37.3K	SEC
Urovant Sciences Ltd.Listing unverified	May 23, 2019	Buy	9,995	8.52 USD	$85.2K	SEC
Urovant Sciences Ltd.Listing unverified	May 23, 2019	Buy	5,033	8.06 USD	$40.6K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	8,285	7.98 USD	$66.1K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	6,200	7.36 USD	$45.6K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	1,715	8.39 USD	$14.4K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	5,408	6.79 USD	$36.7K	SEC
Sio Gene Therapies Inc.Listing unverified	Mar 19, 2019	Buy	6,666,667	1.50 USD	$10M	SEC
Sio Gene Therapies Inc.Listing unverified	Dec 20, 2018	Buy	10,000,000	1.00 USD	$10M	SEC
Arbutus Biopharma CorpListing on record	Jan 16, 2018	BuyD (derivative)	664,000	100.00 USD	$66.4M	SEC
Arbutus Biopharma CorpListing on record	Oct 17, 2017	BuyD (derivative)	500,000	100.00 USD	$50M	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-25,200	7.78 USD	$196.1K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-51,024	7.57 USD	$386.3K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-36,000	7.71 USD	$277.6K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-16,425	7.67 USD	$126K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,367	7.95 USD	$58.6K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,500	8.30 USD	$62.3K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,144	7.91 USD	$56.5K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 11, 2019	Buy	7,189	8.58 USD	$61.7K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 11, 2019	Buy	6,649	7.97 USD	$53K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 11, 2019	Buy	7,500	8.35 USD	$62.6K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	5,071	7.70 USD	$39K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	300	8.91 USD	$2.7K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	5,424	7.71 USD	$41.8K	SEC
Urovant Sciences Ltd.Listing unverified	Jun 3, 2019	Buy	6,951	7.97 USD	$55.4K	SEC
Urovant Sciences Ltd.Listing unverified	May 23, 2019	Buy	4,802	7.76 USD	$37.3K	SEC
Urovant Sciences Ltd.Listing unverified	May 23, 2019	Buy	9,995	8.52 USD	$85.2K	SEC
Urovant Sciences Ltd.Listing unverified	May 23, 2019	Buy	5,033	8.06 USD	$40.6K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	8,285	7.98 USD	$66.1K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	6,200	7.36 USD	$45.6K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	1,715	8.39 USD	$14.4K	SEC
Urovant Sciences Ltd.Listing unverified	May 20, 2019	Buy	5,408	6.79 USD	$36.7K	SEC
Sio Gene Therapies Inc.Listing unverified	Mar 19, 2019	Buy	6,666,667	1.50 USD	$10M	SEC
Sio Gene Therapies Inc.Listing unverified	Dec 20, 2018	Buy	10,000,000	1.00 USD	$10M	SEC
Arbutus Biopharma CorpListing on record	Jan 16, 2018	BuyD (derivative)	664,000	100.00 USD	$66.4M	SEC
Arbutus Biopharma CorpListing on record	Oct 17, 2017	BuyD (derivative)	500,000	100.00 USD	$50M	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-25,200	7.78 USD	$196.1K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-51,024	7.57 USD	$386.3K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-36,000	7.71 USD	$277.6K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jun 12, 2014	Sell	-16,425	7.67 USD	$126K	SEC